# Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

> **NCT05384535** · NA · RECRUITING · sponsor: **Northwell Health** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer
- Magnetic Resonance Imaging
- Population at Risk

## Interventions

- **DIAGNOSTIC_TEST:** Bi-parametric MRI

## Key facts

- **NCT ID:** NCT05384535
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-15
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384535, "Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05384535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*